SPEAKER:
Norman Vossschulte, VP Fan Experience & Sustainability, Philadelphia Eagles
KEY TAKEAWAYS:
• Storytelling drives engagement better than transactional loyalty programs
• Eagles maintain 99% season ticket membership
• Employee experience directly determines customer experience quality
• First and Goal framework translates abstract values into daily behaviors
• Common language extends beyond words to body language and humor
When Norman Vossschulte took the stage at Reuters Events Customer Engagement Conference, pharma executives expecting another industry case study instead encountered a challenge: what can healthcare learn from football fans? His answer centered on an unexpected insight from his time at Disney. "Disney would tell you we are experts at one thing. Everything we do, we start at the base of this one thing," Vossschulte explained. "Storytelling. It starts with a mouse." This wasn't nostalgia—it was strategic doctrine. Disney employees aren't called employees but cast members, operating within narratives where guests become story participants. Vossschulte connected this to fundamental human psychology: "I believe storytelling is the key to engaging humans. This goes back to the Stone Age." For pharma companies investing millions in patient support programs, the provocation resonated. If entertainment masters emotional engagement through narrative, what does pharma's transactional approach miss?
The Philadelphia Eagles don't manage touchpoints—they orchestrate stories. Vossschulte structures fan experience across three acts rather than operational checkpoints, transforming what could be transactional attendance into emotional narrative. The approach delivers extraordinary business results. "99% of our tickets are all season ticket members," Vossschulte shared, which demonstrate how story-driven engagement creates demand transcending convenience or cost.
The narrative structure follows classic storytelling principles.
"Stories have a beginning, a middle, and an end. What does that mean? Well, our beginning is our tailgate," Vossschulte described. "Then there's kickoff... And then of course, you have the game, and then you have the end of the game."
Each phase receives deliberate design attention. The tailgate hosts 40,000 fans across 20,000 parking spots. Kickoff includes pregame experiences like holding the American flag on-field. The conclusion doesn't simply eject attendees but features staff farewells—"Have a good night. Thank you guys so much for coming"—even after losses.
Pharma patient journeys often fragment across disconnected functions. Diagnosis belongs to one team, treatment initiation to another, adherence to patient services, outcomes to medical affairs. Each touchpoint may perform adequately in isolation yet lack narrative cohesion. Patients don't experience their healthcare as operational stages—they live stories with emotional arcs, uncertainty, hope, setbacks, and milestones. The Eagles demonstrate that organizations capturing this narrative architecture don't just improve satisfaction scores—they create demand that waiting lists measure rather than market share calculations.
Operational excellence at scale requires more than training manuals. The Eagles deploy "First and Goal," a framework translating customer-centricity into memorable daily behaviors for thousands of game-day staff. The acronym structures specific commitments: First, I will create a memorable fan experience. Greet every fan with a smile. Own my zone. Appreciate everyone. Live the mission: safe, clean, and friendly.
The smiling requirement isn't superficial sentiment but behavioral science application. Vossschulte referenced Ivy League research demonstrating measurable health benefits from smiling—endorphin release that physiologically improves wellbeing. More remarkably, studies show smiling at others creates health effects in recipients. "When you smile at other people, it actually has an effect on them. A healthy effect. You can, in fact, make people healthier by smiling at them," he emphasized. The framework's power emerged through cultural transformation metrics rather than customer surveys.
"I retrained our whole building, and I knew I had succeeded one day when I came in through security and our security guards were like, can't come in here today," Vossschulte recounted. Concerned something was amiss, he pressed for explanation. "You're not smiling." Security enforcing cultural standards on leadership confirmed the framework had penetrated organizational identity beyond compliance theater.
This mirrors Disney's "keys of excellence" and Chick-fil-A's service model—companies where operational frameworks become cultural languages enabling consistent experiences across thousands of employees. For pharma companies, the application challenge involves translating these principles across field forces, patient services, medical affairs, and digital channels. Each function currently operates with distinct metrics, incentives, and vocabularies. A unifying framework grounded in behavioral science rather than corporate platitudes could align disparate touchpoints into coherent brand experiences.
The approach requires prioritizing people over policies. Vossschulte contrasted this with various guest service counter experiences where procedures supersede customer needs. "Policy over customer service. Never a good thing," he observed. "But your fans, your staff, your customers, your clients—everyone has to feel that with you, they come first." In healthcare, regulatHI normaory requirements and clinical protocols create necessary constraints. Yet within those boundaries, organizations choose whether patients encounter bureaucratic machinery or human-centered service. The Eagles prove that customer-first philosophy scales through cultural frameworks, not policy exceptions.
The Eagles maintain unprecedented demand without formal loyalty programs. No points systems, no tiered memberships, no "buy more, get more" mechanics. Vossschulte critiqued this industry standard directly:
"There was this big push many years ago to create these loyalty programs. Buy more, you get more," he noted. "But if it's not sincere, if it's not a real engagement, if it's not really that back and forth with humans, if it's not a story behind it, it really doesn't mean much."
Authentic relationship-building replaces transactional schemes. Staff receive training on appreciating diverse needs—neurodivergent fans, ADA requirements, children whose stadium view consists primarily of adult anatomy. "Get on their level. Hey. What's up? High five. Got your jersey on. We might need you on the field later on," Vossschulte described as the approach to young fans. These moments cost nothing financially yet build emotional bonds mechanical reward programs cannot replicate.
The concept extends through "common language"—a principle Vossschulte considers humanity's superpower. "I believe that we humans have a superpower, and that is language," he explained. "If we all spoke the same language—and by the way, that's not just speaking English... that also means body language. It also means smiling language." Common language creates organizational cohesion across functional silos. At his previous engineering firm, architects and mathematicians couldn't collaborate effectively despite technical competence. Shared vocabulary, behavioral norms, and cultural touchpoints enable coordination that org charts alone cannot achieve.
For pharma companies, patient support programs often resemble the transactional loyalty schemes Vossschulte critiqued. Copay cards, refill reminders, nurse hotlines—all valuable services, yet mechanistic rather than relational. As biosimilar competition intensifies and clinical differentiation narrows, authentic relationships may constitute the only sustainable advantage. Patients don't develop loyalty to prior authorization support—they develop loyalty to organizations demonstrating genuine understanding of their lived experience.
The synthesis reveals transferable principles: narrative architecture structuring journeys as stories rather than processes, cultural frameworks codifying values into scalable behaviors, employee experience investment recognizing staff as experience delivery mechanisms, authenticity prioritized over transactional mechanics, and common language unifying cross-functional collaboration. Healthcare engagement operates under regulatory constraints, clinical complexity, and ethical considerations that sports entertainment doesn't face. Yet underlying psychology remains constant—humans respond to stories, authentic relationships, and consistent experiences regardless of industry context.
Practical applications emerge across pharma operations. Patient journey mapping could adopt narrative frameworks identifying emotional arcs, not just clinical milestones. Cross-functional customer experience frameworks like "First and Goal" could align field teams, patient services, medical affairs, and digital channels around shared behavioral commitments. Service standards grounded in behavioral science—like the smiling research—provide evidence-based rationale for seemingly soft skills. Patient support programs could emphasize relational depth over transactional breadth, building fewer but more meaningful touchpoints.
Vossschulte closed with an unlikely organizational unifier: dad jokes. "I actually, with our game day staff, my common language is dad jokes," he revealed. "It has literally united our game day staff. If you go to any other stadium in the NFL, I'm actually now known as the dad joke teller." The anecdote transcends humor—it demonstrates how seemingly trivial cultural touchpoints create organizational identity and cross-functional cohesion that formal programs cannot. Staff now approach him demanding jokes. Colleagues from other teams recognize him by this characteristic.
The metaphor applies directly to healthcare engagement. Pharma companies invest heavily in sophisticated CRM platforms, omnichannel orchestration, and predictive analytics. These tools matter. But organizations often underinvest in the cultural elements creating human connection—shared languages, behavioral norms, authentic moments, narrative coherence.
The Eagles prove that customer engagement excellence doesn't require revolutionary technology or massive budgets. It requires commitment to storytelling, cultural frameworks enabling consistent service, employee experience investment, authenticity over transactions, and common languages unifying diverse teams. These principles cost little financially yet demand significant leadership commitment.
"Investing in service is a smart business decision," Vossschulte emphasized. "If you give, you will get back. I don't know, the universe just works that way."
For pharma executives seeking sustainable competitive advantage in patient engagement, the lessons from Lincoln Financial Field offer unexpected but actionable guidance: sometimes the best customer engagement strategy starts not with loyalty points, but with a smile and a story.
To get you highlights of Pharma Customer Engagement USA faster, we are using generative AI technology to summarise the transcripts of the sessions. If you have any feedback about the summary, please contact lucy.fisher@thomsonreuters.com
Discover more on this topic at Pharma USA 2026 (March 17-18, Philadelphia) - North America's largest cross-functional pharma gathering. Visit the website here.
